{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:58:43Z","timestamp":1785279523180,"version":"3.55.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Peptide-based cancer vaccines represent a promising immunotherapeutic strategy aimed at inducing tumor-specific immune responses through the targeting of tumor-associated antigens and neoantigens. Recent advances in next-generation sequencing and immunogenomics have accelerated the identification of candidate neoantigens; however, the development of effective peptide vaccines remains limited by challenges related to antigen selection, HLA polymorphism, antigen processing, and variability in immunogenicity. Artificial intelligence (AI), including machine learning and deep learning approaches, has emerged as a transformative tool capable of addressing these limitations through large-scale integration and analysis of genomic, transcriptomic, proteomic, and immunological data. In this review, we summarize the current role of AI across the peptide cancer vaccine development pipeline, from neoantigen discovery and epitope prioritization to prediction of peptide\u2013HLA binding, antigen presentation, and T-cell receptor recognition. We discuss the application of modern computational frameworks, including pan-allelic prediction models, transformer-based architectures, immunopeptidomics-informed learning, and multi-modal AI systems integrating tumor and immune microenvironment data. Furthermore, we examine the clinical translation of personalized neoantigen vaccines, including their combination with immune checkpoint inhibitors and their emerging role in aggressive malignancies such as glioblastoma. Despite substantial progress, significant challenges remain, including high false-positive prediction rates, limited diversity of training datasets, biological complexity of immunogenicity, and regulatory and manufacturing barriers associated with individualized therapies. Continued integration of AI-driven prediction tools with experimental validation and translational immunology will be essential for the development of clinically effective and scalable precision cancer vaccines.<\/jats:p>","DOI":"10.3389\/fgene.2026.1875066","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:10:29Z","timestamp":1785276629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction"],"prefix":"10.3389","volume":"17","author":[{"given":"Petar","family":"Brlek","sequence":"first","affiliation":[{"name":"St. Catherine Specialty Hospital","place":["Zagreb, Croatia"]},{"name":"International Center for Applied Biological Research","place":["Zagreb, Croatia"]},{"name":"School of Medicine, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Department of Molecular Biology, Faculty of Science, University of Zagreb","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Koli\u0107","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, University Hospital Center Zagreb","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Buli\u0107","sequence":"additional","affiliation":[{"name":"St. Catherine Specialty Hospital","place":["Zagreb, Croatia"]},{"name":"International Center for Applied Biological Research","place":["Zagreb, Croatia"]},{"name":"School of Medicine, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Algebra Bernays University","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedrana","family":"\u0160karo","sequence":"additional","affiliation":[{"name":"International Center for Applied Biological Research","place":["Zagreb, Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Primorac","sequence":"additional","affiliation":[{"name":"St. Catherine Specialty Hospital","place":["Zagreb, Croatia"]},{"name":"International Center for Applied Biological Research","place":["Zagreb, Croatia"]},{"name":"School of Medicine, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek","place":["Osijek, Croatia"]},{"name":"Eberly College of Science, The Pennsylvania State University","place":["State College, PA, United States"]},{"name":"School of Medicine, University of Split","place":["Split, Croatia"]},{"name":"The Henry C. Lee College of Criminal Justice and Forensic Sciences, University of New Haven","place":["New Haven, CT, United States"]},{"name":"Sana Kliniken Oberfranken","place":["Coburg, Germany"]},{"name":"School of Medicine, University of Rijeka","place":["Rijeka, Croatia"]},{"name":"School of Medicine, University of Mostar","place":["Mostar, Bosnia and Herzegovina"]},{"name":"National Forensic Sciences University","place":["Gandhinagar, India"]},{"name":"School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9749363","DOI":"10.1155\/2022\/9749363","article-title":"Development of peptide-based vaccines for cancer","volume":"2022","author":"Abd-Aziz","year":"2022","journal-title":"J. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10238-026-02107-5","article-title":"Artificial intelligence in immunotherapy: revolutionizing diagnostic and therapeutic applications in cancer and autoimmune diseases","volume":"26","author":"Alshorman","year":"2026","journal-title":"Clin. Exp. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri.2016.9","article-title":"AIRE expands: new roles in immune tolerance and beyond","volume":"16","author":"Anderson","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00262-017-2001-3","article-title":"MuPeXI: prediction of neo-epitopes from tumor sequencing data","volume":"66","author":"Bjerregaard","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.3390\/cancers13133247","article-title":"Integrative cBioPortal analysis revealed molecular mechanisms that regulate EGFR-PI3K-AKT-mTOR pathway in diffuse gliomas of the brain","volume":"13","author":"Brlek","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3390\/cancers17213500","article-title":"Advances in precision oncology: from molecular profiling to regulatory-approved targeted therapies","volume":"17","author":"Brlek","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ai7010011","article-title":"AI-Driven advances in precision oncology: toward optimizing cancer diagnostics and personalized treatment","volume":"7","author":"Buli\u0107","year":"2026","journal-title":"AI"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1054231","DOI":"10.3389\/fonc.2022.1054231","article-title":"Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy","volume":"12","author":"Cai","year":"2023","journal-title":"Front. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"03.31.715361","DOI":"10.64898\/2026.03.31.715361","article-title":"A structure-informed deep learning framework for modeling TCR-peptide-HLA interactions","author":"Cao","year":"2026"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1651533","DOI":"10.3389\/fimmu.2025.1651533","article-title":"AI\/ML-empowered approaches for predicting T cell-mediated immunity and beyond","volume":"16","author":"Chao","year":"2025","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","article-title":"Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications","volume":"32","author":"Chen","year":"2016","journal-title":"Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.7150\/thno.38742","article-title":"Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e70412","DOI":"10.1002\/mco2.70412","article-title":"The role of immune checkpoint inhibitors in cancer therapy: mechanism and therapeutic advances","volume":"6","author":"Chen","year":"2020","journal-title":"MedComm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.isci.2023.108613","article-title":"HLAEquity: examining biases in pan-allele peptide-HLA binding predictors","volume":"27","author":"Conev","year":"2023","journal-title":"iScience"},{"key":"B15","article-title":"DRAGEN secondary analysis","year":"2024","journal-title":"Illumina"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1620572","DOI":"10.3389\/frai.2025.1620572","article-title":"Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics-yesterday, today, and tomorrow","volume":"8","author":"Elfatimi","year":"2025","journal-title":"Front. Artif. Intell."},{"key":"B17","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gkz836","article-title":"The international genome sample resource (IGSR) collection of open human genomic variation resources","volume":"48","author":"Fairley","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.7150\/ijms.120868","article-title":"Advances in tumor antigen vaccines: a new frontier in cancer immunotherapy","volume":"22","author":"Feng","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.iotech.2021.100052","article-title":"Computational cancer neoantigen prediction: current status and recent advances","volume":"12","author":"Fotakis","year":"2021","journal-title":"Immunooncol Technol."},{"key":"B20","author":"Garrison","year":"2012","journal-title":"Haplotype-Based Variant Detection from short-read SequencingarXiv Preprint arXiv:1207.3907"},{"key":"B21","volume-title":"Python. Cancer Immune Recognition Lab","year":"2025"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2026012335","DOI":"10.20944\/preprints202601.2335.v1","article-title":"From prediction to synthesis: generative AI architectures and digital twins for the future of vaccines and immuno-oncology","author":"Gote","year":"2026","journal-title":"Preprints"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41591-018-0203-7","article-title":"Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes","volume":"24","author":"Graham","year":"2018","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/eji.201141774","article-title":"Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity","volume":"42","author":"Harndahl","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","article-title":"pVACtools: a computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1530305","DOI":"10.3389\/fimmu.2025.1530305","article-title":"Molecular biology of the deadliest cancer - glioblastoma: what do we know?","volume":"16","author":"Ismailov","year":"2025","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"20499361251411188","DOI":"10.1177\/20499361251411188","article-title":"Advancing peptide-based vaccines against viral pathogens: a narrative review","volume":"13","author":"Jahantigh","year":"2026","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"RP93934","DOI":"10.7554\/eLife.93934","article-title":"Enhancing TCR specificity predictions by combined pan- and peptide-specific training, loss-scaling, and sequence similarity integration","volume":"12","author":"Jensen","year":"2024","journal-title":"Elife"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41541-025-01069-1","article-title":"HLA I immunopeptidome of synthetic long peptide pulsed human dendritic cells for therapeutic vaccine design","volume":"10","author":"Kessler","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biochem5020005","article-title":"Advances in personalized cancer vaccine development: AI applications from neoantigen discovery to mRNA formulation","volume":"5","author":"Kong","year":"2025","journal-title":"Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkac902","article-title":"The cancer epitope database and analysis resource (CEDAR)","volume":"51","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6870","DOI":"10.1038\/s41467-024-51315-8","article-title":"A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine","volume":"15","author":"Latzer","year":"2024","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/cells12172147","article-title":"Dendritic cell vaccines: a shift from conventional approach to new generations","volume":"12","author":"Lee","year":"2023","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e2320879121","DOI":"10.1073\/pnas.2320879121","article-title":"Principles of peptide selection by the transporter associated with antigen processing","volume":"121","author":"Lee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41592-025-02910-0","article-title":"Assessment of computational methods in predicting TCR-epitope binding recognition","volume":"23","author":"Lu","year":"2026","journal-title":"Nat. Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molimm.2021.12.013","article-title":"Spotlight on TAP and its vital role in antigen presentation and cross-presentation","volume":"142","author":"Mantel","year":"2022","journal-title":"Mol. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-Presented peptides by incorporating antigen processing","volume":"11","author":"O'Donnell","year":"2020","journal-title":"Cell Syst."},{"key":"B42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41587-026-03018-2","article-title":"The promises and challenges of neoantigen cancer vaccines","volume":"44","author":"Ott","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","article-title":"Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer","volume":"40","author":"Ouspenskaia","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02839-x","article-title":"Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic","author":"Park","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"btad284","DOI":"10.1093\/bioinformatics\/btad284","article-title":"epiTCR: a highly sensitive predictor for TCR-peptide binding","volume":"39","author":"Pham","year":"2023","journal-title":"Bioinformatics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","article-title":"A universal SNP and small-indel variant caller using deep neural networks","volume":"36","author":"Poplin","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/biomedicines13061452","article-title":"Emerging chemotherapy targets: insights from advances in glioma treatment","volume":"13","author":"Rezk","year":"2025","journal-title":"Biomedicines"},{"key":"B52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"142919","DOI":"10.1101\/142919","article-title":"Vaxrank: a computational tool for designing personalized cancer vaccines","author":"Rubinsteyn","year":"2018","journal-title":"bioRxiv"},{"key":"B54","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1158\/2159-8290.CD-24-0934","article-title":"PGV001, a multi-peptide personalized neoantigen vaccine platform: phase I study in patients with solid and hematologic malignancies in the adjuvant setting","volume":"15","author":"Saxena","year":"2025","journal-title":"Cancer Discov."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"03.09.710672","DOI":"10.64898\/2026.03.09.710672","article-title":"Decoding epitope immunodominance in HIV env using cryoEM and machine learning","author":"Schuhmacher","year":"2026","journal-title":"Prepr. Biorxiv."},{"key":"B57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1301100","DOI":"10.3389\/fimmu.2023.1301100","article-title":"Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy","volume":"14","author":"Shah","year":"2023","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"B60","article-title":"ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials. Preprint. ArXiv. 2025","author":"Singhal","year":"2025","journal-title":"arXiv:2512.08226v1"},{"key":"B61","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/vaccines13050473","article-title":"Considerations for mRNA product development, regulation and deployment across the lifecycle","volume":"13","author":"Skerritt","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"bbab569","DOI":"10.1093\/bib\/bbab569","article-title":"Multimodal deep learning for biomedical data fusion: a review","volume":"23","author":"Stahlschmidt","year":"2022","journal-title":"Brief. Bioinform"},{"key":"B63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","article-title":"The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives","volume":"18","author":"Sun","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13073-025-01450-8","article-title":"Predicting MHC-I ligands across alleles and species: how far can we go?","volume":"17","author":"Tadros","year":"2025","journal-title":"Genome Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-019-0023-9","article-title":"The global challenge of cancer","volume":"1","year":"2020","journal-title":"Nat. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/pharmaceutics15061648","article-title":"Targeting peptides: the new generation of targeted drug delivery systems","volume":"15","author":"Todaro","year":"2023","journal-title":"Pharmaceutics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.4110\/in.2023.23.e41","article-title":"The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and cancer","volume":"23","author":"Topchyan","year":"2023","journal-title":"Immune Netw."},{"key":"B69","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41598-019-56943-5","article-title":"Automated flow synthesis of tumor neoantigen peptides for personalized immunotherapy","volume":"10","author":"Truex","year":"2020","journal-title":"Sci. Rep."},{"key":"B70","volume-title":"Genomics in the Cloud","author":"Van der Auwera","year":"2026"},{"key":"B71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41541-025-01258-y","article-title":"AI-driven epitope prediction: a system review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B72","doi-asserted-by":"publisher","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","article-title":"The immune epitope database (IEDB): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1002350","DOI":"10.37349\/etat.2025.1002350","article-title":"Cancer vaccines: advances, hurdles, and future directions","volume":"6","author":"Vlachostergios","year":"2025","journal-title":"Explor Target Antitumor Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e70018","DOI":"10.1002\/prca.70018","article-title":"Artificial intelligence and the evolving landscape of immunopeptidomics","volume":"19","author":"Vo","year":"2025","journal-title":"Proteomics Clin. Appl."},{"key":"B75","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41423-020-0463-2","article-title":"MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"102968","DOI":"10.1016\/j.mtbio.2026.102968","article-title":"Precise regulation of cancer vaccine and immune checkpoint inhibitor synergy potentiates immunotherapy with reduced immune-related pneumonitis","volume":"37","author":"Wang","year":"2026","journal-title":"Mater Today Bio"},{"key":"B77","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/cancers18010144","article-title":"Advances in neoantigen-based cancer vaccines","volume":"18","author":"Wu","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.csbj.2023.11.037","article-title":"TCR-ESM: employing protein language embeddings to predict TCR-peptide-MHC binding","volume":"23","author":"Yadav","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1039\/d3cb00208j","article-title":"Leveraging machine learning models for peptide-protein interaction prediction","volume":"5","author":"Yin","year":"2024","journal-title":"RSC Chem. Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1733549","DOI":"10.3389\/fcell.2025.1733549","article-title":"Neoantigens in cancer immunoediting: from mechanisms to personalized vaccines in breast cancer","volume":"13","author":"Zeng","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"bbaf302","DOI":"10.1093\/bib\/bbaf302","article-title":"Computational methods and data resources for predicting tumor neoantigens","volume":"26","author":"Zhao","year":"2025","journal-title":"Brief. Bioinform"},{"key":"B85","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/cimb47110945","article-title":"Molecular mechanism for the selective presentation of antigenic peptides by major histocompatibility complex class I and class II molecules: a hypothesis","volume":"47","author":"Zhu","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41420-025-02698-0","article-title":"Current landscape of the immunoproteasome: implications for disease and therapy","volume":"11","author":"Zou","year":"2025","journal-title":"Cell Death Discov."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1875066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:10:31Z","timestamp":1785276631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1875066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":86,"alternative-id":["10.3389\/fgene.2026.1875066"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1875066","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1875066"}}